| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | THERAPEUTIC LIGHT BOX FOR THE TREATMENT OF MAJOR DEPRESSION WITH SEASONAL PATTERN - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195979 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CARDIAC CONTRACTILITY MODULATION (I.E., OPTIMIZER SMART) FOR THE TREATMENT OF HEART FAILUREPayerPolicy · BCBSM-2197466 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOTHELIAL FUNCTION ASSESSMENT( policy retiredPayerPolicy · BCBSM-2041205 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY/DYSPLASIA (ARVC/D)PayerPolicy · BCBSM-2007395 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HOME MONITORING DEVICE FOR AGE-RELATED MACULAR DEGENERATION - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193213 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCN ONLY - SPEECH AND SWALLOWING THERAPY (replaced by Doc ID 2175952)PayerPolicy · BCBSM-2008113 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCRANIAL MAGNETIC STIMULATION AS A TREATMENT OF DEPRESSION AND OTHER PSYCHIATRIC/NEUROLOGIC DISORDERSPayerPolicy · BCBSM-77020 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOCULAR RADIATION THERAPY FOR AGE-RELATED MACULAR DEGENERATION - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193860 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM BIOMARKER HUMAN EPIDIDYMIS PROTEIN 4 (HE4) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198899 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONTRADITIONAL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2205378 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - INOTUZUMAB OZOGAMICIN: BESPONSA (J9229)PayerPolicy · BCBSM-2091529 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FOSNETUPITANT PALONOSETRON INJECTION: AKYNZEO (C9033)PayerPolicy · BCBSM-2099264 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR TAY-SACHS DISEASE (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209357-AB8E3155A0 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - LUMOXITI (MOXETUMOMAB PASUDOTOX-TDFK) (retired as 10/12/2023)PayerPolicy · BCBSM-2103567 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATE CANCER EARLY DETECTION: BIOMARKERS PRIOR TO BIOPSY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198893 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENE EXPRESSION PROFILE ANALYSIS FOR RISK STRATIFICATION FOR PROSTATE CANCER MANAGEMENTPayerPolicy · BCBSM-2065123 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GROWING RODS FOR SCOLIOSIS (E.G., MAGEC SPINAL BRACING AND DISTRACTION SYSTEM)PayerPolicy · BCBSM-2108870 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPUTER-AIDED EVALUATION AS AN ADJUNCT TO MAGNETIC RESONANCE IMAGING FOR PROSTATE CANCERPayerPolicy · BCBSM-2187369 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE BONE-CONDUCTION AND BONE-ANCHORED HEARING DEVICES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193812 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT- HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR CNS EMBRYONAL TUMORS AND EPENDYMOMAPayerPolicy · BCBSM-2022264 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC ESOPHAGEAL SPHINCTER AUGMENTATION TO TREAT GASTROESOPHAGEAL REFLUX DISEASE (GERD)PayerPolicy · BCBSM-2032188 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM MARKERS FOR THE DIAGNOSIS AND CARE OF INFLAMMATORY BOWEL DISEASE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198900 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LABORATORY TESTS POST TRANSPLANT (KIDNEY, HEART AND LUNG) AND FOR HEART FAILUREPayerPolicy · BCBSM-104426 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EYE MOVEMENT DESENSITIZATION AND REPROCESSING FOR POST TRAUMATIC STRESS DISORDER (PTSD)PayerPolicy · BCBSM-2017931 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR GERM-CELL TUMORS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195788 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSTSURGICAL HOME USE OF LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXISPayerPolicy · BCBSM-2030257 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MENISCAL ALLOGRAFTS AND OTHER MENISCAL IMPLANTS (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209359-8FFEFCF3B6 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPEECH AND LANGUAGE PATHOLOGY/SWALLOWING REHABILITATION (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210511-6C589835B7 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCUTANEOUS ELECTRICAL MODULATION PAIN REPROCESSING (SCRAMBLER THERAPY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195920 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), INCLUDING SUBCUTANEOUS ICDS AND SUBSTERNAL ICDSPayerPolicy · BCBSM-2197929 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING-GENE EXPRESSION PROFILING FOR UVEAL MELANOMA - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198881 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL OVARIAN CANCERPayerPolicy · BCBSM-2026842-9FD3019F20 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER USING PERMANENTLY IMPLANTED SEEDSPayerPolicy · BCBSM-77460 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MEASUREMENT OF SERUM AND ANTI-DRUG ANTIBODY LEVELS FOR SELECTED BIOLOGIC AGENTSPayerPolicy · BCBSM-2033118 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVENOUS ANESTHETICS FOR THE TREATMENT OF CHRONIC PAIN AND PSYCHIATRIC DISORDERS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195792 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA AND GASTRIC PERORAL ENDOSCOPIC MYOTOMY FOR GASTROPARESISPayerPolicy · BCBSM-2201180 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - SIPULEUCEL-T: PROVENGE (Q2043)PayerPolicy · BCBSM-2070041 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CRYOABLATION OR CRYONEUROLYSIS (E.G., IOVERA° SYSTEM) OF PERIPHERAL NERVES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193020-591A67CA8A | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) FOR THE TREATMENT OF CEREBRAL VASOSPASM - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197883 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POLYMERASE CHAIN REACTION (PCR) TESTING IN THE DIAGNOSIS OF ONYCHOMYCOSIS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196227 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - ZIV-AFLIBERCEPT: ZALTRAP (J9400)PayerPolicy · BCBSM-2070037 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PCR PANEL TESTING FOR GRAM-NEGATIVE BACILLUS ANTIMICROBIAL RESISTANCE GENESPayerPolicy · BCBSM-2081564 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOFREQUENCY ABLATION OF BASIVERTEBRAL NERVE FOR LOW BACK PAIN (I.E. INTRACEPT)PayerPolicy · BCBSM-2143173 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FISH OIL TRIGLYCERIDES: OMEGAVEN (no code)PayerPolicy · BCBSM-2102115 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | VESTRONIDASE ALFA-VJBK: MEPSEVII (J3397)PayerPolicy · BCBSM-2087168 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ABSORBABLE NASAL IMPLANT FOR THE TREATMENT OF NASAL VALVE COLLAPSE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2201426 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERORAL ENDOSCOPIC MYOTOMY FOR TREATMENT OF ESOPHAGEAL ACHALASIA OR GASTROPARESIS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194115-D31D2593C2 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | REFRACTIVE KERATOPLASTIES, PHOTOTHERAPEUTIC KERATECTOMY AND IMPLANTATION OF INTRASTROMAL CORNEAL RING SEGMENTSPayerPolicy · BCBSM-77458 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PATIENT-SPECIFIC CUTTING GUIDES AND CUSTOM KNEE IMPLANTS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194066 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE GROWTH STIMULATION ELECTRICAL BONE GROWTH STIMULATION OF THE APPENDICULAR SKELETONPayerPolicy · BCBSM-2030583 | New policy |
|---|